TWC Tech Holdings II Files Investor Presentation in Support of Cellebrite Deal

TWC Tech Holdings II

TWC Tech Holdings II in an 8-K filing today included an investor presentation highlighting its pending merger with Israel-based tech firm Cellebrite.

Terms call for Cellebrite to receive $580 million in cash, including a $300 million PIPE.

If shareholders approve the deal, following the merger Cellebrite will list on the Nasdaq under CLBT. The pro forma implied equity value of Cellebrite post-merger is expected to be approximately $2.4 billion.

Cellebrite offers technology solutions to aid law enforcement in criminal investigations, such as software and hardware for hacking into locked smart phones. Read more.

Total
0
Shares
Related Posts
Read More

Digital Health Deploys Another 3-Month Extension

Digital Health has mergers pending with VSee Lab, a telehealth software company, and iDoc Telehealth, a neurocritical care and intensive care telehealth provider. At deal announcement in June 2022, the transaction had a valuation of approximately $110 million for the combined entity.